1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Global Gene Expression Reagent Trends Industry

Global Gene Expression Reagent Trends Industry

  • January 2014
  • -
  • Global Industry Analysts
  • -
  • 15 pages

Gene Expression refers to the production of functional products, most commonly proteins, using information saved in a specific gene. Gene expression is a key process undertaken by all life forms, including unicellular as well as multicellular organisms, primarily for generating their macromolecular machinery.

The report analyzes and presents an overview of Gene Expression Reagents market worldwide. Supported with 3 market data tables, the report provides a review of global market trends, and various strategic industry activities of major companies witnessed by the industry over the last few years. In addition, 30 companies operating in the Gene Expression Reagents arena worldwide including Affymetrix Inc., Agilent Technologies Inc., GE Healthcare, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific Inc., and others are profiled.

Table Of Contents

Global Gene Expression Reagent Trends Industry

1.GENE EXPRESSION REAGENTS - AN OVERVIEW

An Introduction

Table 1: Major Individual qPCR Reagent Players Market Share by Value (2012) for Life Technologies Corporation, Roche Applied Science, Bio-Rad Laboratories Inc., Qiagen, and Others

Table 2: Global Top 3 Gene Sequencing Tool Manufacturers' Market Share by Value (2012) for Illumina, Roche, Life Sciences, and Others

Table 3: Global Top 3 Life Science Instrument Manufacturers' Market Shares by Value (2012) for Life Technologies, Becton Dickinson, GE Healthcare, and Others

2.RECENT INDUSTRY ACTIVITY

Sigma-Aldrich Inks Agreement with Olink Bioscience

Synpromics Receives Grant from Technology Strategy Board

Thermo Fisher Scientific to Acquire Life Technologies

Agilent Technologies Inks Licensing Agreement with SRI International

Agilent Technologies Inks Agreement with Roche

ZyGEM Corp Signs Agreement with Quanta BioSciences

Affymetrix Receives US FDA Clearance for Gene Profiling Reagents

3.PRODUCT LAUNCHES/TECHNOLOGICAL INNOVATIONS

Agilent Technologies Launches SureScanDx Microarray Scanner

Illumina Introduces Universal Real-Time PCR Reagent Portfolio

Life Technologies Introduces Compendia Oncomine® Next Generation Sequencing Power Tools

Mirus Bio Develops TransIT-BrCa Transfection Reagent

Affymetrix Launches Axiom® Genotyping Arrays

Affymetrix Introduces SensationPlusâ„¢ FFPE Reagent Kit

Agilent Technologies Unveils Agilent SurePrint G3 Human Gene Expression v2 Microarray

Agilent Unveils Agilent CytoGenomics 1.0

Agilent Technologies Introduces GeneSpring GX 11.5 Bioinformatics Software

Agilent Technologies Unveils New Exon Analysis Solution

4.MARKET PARTICIPANTS

Affymetrix, Inc. (USA)

Agendia, Inc. (USA)

Agilent Technologies, Inc. (USA)

Applied Biosystems, Inc. (USA)

Cepheid (USA)

Clontech Laboratories, Inc. (USA)

Complete Genomics, Inc. (USA)

Cytocell Ltd. (UK)

DNA LandMarks, Inc. (Canada)

DNAVision SA (Belgium)

Dynex Technologies, Inc. (USA)

Epicentre® Biotechnologies (USA)

Eurofins Medigenomix GmbH (Germany)

Eurogentec SA (Belgium)

Exiqon A/S (Denmark)

GE Healthcare (UK)

Geneworks Pty., Ltd. (Australia)

Genisphere LLC (USA)

Illumina, Inc. (USA)

Inqaba Biotechnical Industries Pty., Ltd. (South Africa)

Life Technologies Corporation (USA)

Mirus Bio LLC (USA)

Ocimum Biosolutions Ltd. (India)

Origene Technologies, Inc. (USA)

Quanta Biosciences, Inc. (USA)

Roche Diagnostics (Switzerland)

Saturn Biotech Ltd. (Australia)

Sequetech Corporation (USA)

Sigma-Aldrich Co. LLC (USA)

Thermo Fisher Scientific, Inc. (USA)

5.APPENDIX



View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Global Gene Expression Analysis Market - Growth, Trends & Forecasts(2017 - 2022 (2017 - 2022)

Global Gene Expression Analysis Market - Growth, Trends & Forecasts(2017 - 2022 (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global gene expression analysis market has been estimated at USD XX billion in 2016 and is projected to reach USD XX billion by 2021, growing at a CAGR of about X% during the forecast period from 2016 ...

VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insights, 2017

VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities ...

2017 Emerging Nucleic Acid Diagnostic Technologies and Strategic Profiles of Leading Suppliers

2017 Emerging Nucleic Acid Diagnostic Technologies and Strategic Profiles of Leading Suppliers

  • $ 3850
  • Industry report
  • March 2017
  • by Venture Planning Group

This 180-page report provides detailed analyses of current and emerging nucleic acid testing technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, ...


Download Unlimited Documents from Trusted Public Sources

Genomics Statistics

  • March 2017
    5 pages
  • Genomics  

View report >

Chromosome Industry in the US

  • March 2017
    3 pages
  • Chromosome  

    Genetic Disorde...  

  • United States  

View report >

Genomics Industry in India

  • March 2017
    2 pages
  • Genomics  

  • India  

    China  

View report >

Genomics Statistics

15 days ago

Related Market Segments :

Gene Expression

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.